Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22
about
MSCs-Derived Exosomes: Cell-Secreted Nanovesicles with Regenerative PotentialInhibition of Myocardial Ischemia/Reperfusion Injury by Exosomes Secreted from Mesenchymal Stem CellsExosomes and Their Therapeutic Potentials of Stem CellsHow to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regenerationMolecular signatures of mesenchymal stem cell-derived extracellular vesicle-mediated tissue repairExosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases?Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarctionStem cell-derived exosomes as a therapeutic tool for cardiovascular diseaseMesenchymal Stem Cells as a Prospective Therapy for the Diabetic FootMicrovesicles as Vehicles for Tissue Regeneration: Changing of the GuardsNon-Coding RNAs in Stroke and NeuroprotectionExosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotectionDisturbance of cardiac gene expression and cardiomyocyte structure predisposes Mecp2-null mice to arrhythmiasNew Delivery Systems of Stem Cells for Vascular Regeneration in IschemiaProgress in Exosome Isolation Techniques.Extracellular vesicles in cardiovascular disease: are they Jedi or Sith?Development of a Novel AAV Gene Therapy Cassette with Improved Safety Features and Efficacy in a Mouse Model of Rett SyndromeImproved MECP2 Gene Therapy Extends the Survival of MeCP2-Null Mice without Apparent Toxicity after Intracisternal Delivery.Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease.Exosomes/miRNAs as mediating cell-based therapy of strokePathologic function and therapeutic potential of exosomes in cardiovascular disease.Emerging roles for extracellular vesicles in tissue engineering and regenerative medicine.MicroRNA-22 impairs anti-tumor ability of dendritic cells by targeting p38.Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications.A New Paradigm in Cardiac Regeneration: The Mesenchymal Stem Cell Secretome.DNA Content in Extracellular Vesicles Isolated from Porcine Coronary Venous Blood Directly after Myocardial Ischemic Preconditioning.Regulatory functions and pathological relevance of the MECP2 3'UTR in the central nervous system.Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.More Than Tiny Sacks: Stem Cell Exosomes as Cell-Free Modality for Cardiac RepairExosomes and exosomal miRNAs in cardiovascular protection and repair.IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics.Tiny Shuttles for Information Transfer: Exosomes in Cardiac Health and Disease.Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4.Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases.How Do Mesenchymal Stem Cells Influence or Are Influenced by Microenvironment through Extracellular Vesicles Communication?Increased Circulating Exosomal miRNA-223 Is Associated with Acute Ischemic Stroke.MSCs-Derived Exosomes and Neuroinflammation, Neurogenesis and Therapy of Traumatic Brain Injury.Mesenchymal Stem Cell-Derived Extracellular Vesicles: Roles in Tumor Growth, Progression, and Drug Resistance.Remote conditioning the heart overview: translatability and mechanism.
P2860
Q26740633-73066A6F-7870-4BFD-9BD6-718109932DDFQ26747038-E4801808-53DF-484A-AF23-881D7D1F799CQ26771909-19C84F23-7FA8-4FC2-B133-A557DD53D54EQ26774939-9FF2250E-C26B-4730-AA9E-1867CD858CAEQ26775288-4C829661-43B8-4F1B-92FC-0DE05D5C2A33Q26777469-6A98248B-45A6-4C92-B3FE-B0A35DBE0732Q27009438-62C38CDE-06B9-4A33-844B-CAF53F531818Q27318070-5591C1B1-C036-4351-9F43-A05A21BB3446Q28071466-A131F1FC-0FA5-450A-B6AD-F6F8E4A5E9CFQ28074810-178A2D95-5749-4D47-899B-76F1843E1346Q28079166-A2E07458-1EA2-4725-B569-15774900A018Q28082190-7C7C9EBF-7D2B-4DC8-8E2A-02DC1A7771BAQ28576809-E93F5BCE-FF1F-4629-9696-0EF6BC45F958Q28648466-672C76F8-5548-43EA-9E84-BB94552FEF56Q30361288-EFB2BBE6-947D-4FC1-80AF-6132E5A87C63Q30361993-4A70EDAA-AFEC-4940-9EEE-EF7FE8CFFD81Q33362561-612B0E00-B2E7-4911-8711-FB5A3D8AC1AAQ33652467-A3AD7959-F0B2-4B32-912A-E94BE510C633Q33655727-E25FF20F-B251-4FFA-9032-BEAE532AA3CEQ33914228-701A1F7C-E358-4F2F-9CDA-34741F222764Q34481082-4A13BB61-8768-428C-94AA-CC5DFE5E7399Q34717025-04F239B1-DEA6-4C2E-80FD-9DE2C099E851Q35064686-85B82A56-0F2F-4664-BABC-35C5FA809EE9Q35234933-6AD346CC-4660-451A-8BDF-4F2C62EBC48DQ35594874-DE0F6F4D-97DA-47E2-85F6-A41C32880DD8Q35621019-325ACBC5-38D9-4F47-86D0-B5A4DC133A9AQ36081700-9D65013F-8BF6-4BE6-9190-CD184F0728B4Q36222710-02A57F39-4DFB-4A1F-83D7-5E33439C15C5Q36422761-424111CB-1B60-49C5-A88A-738C8CC75176Q36550793-EC1663D8-D691-4E66-AA28-6DF256055340Q36816939-B28968D2-453D-498E-B851-06F8C5FE4151Q36835532-F5555EFB-404D-4A55-AB25-5EA75710129AQ36922126-533BF2D9-F94A-4395-AD34-956C8E139B5EQ37482846-B90F2CB8-927F-4A62-9BBA-D45F3B4FB1E7Q37614303-54114FF7-8D19-46B3-BA37-C587E012D085Q37627116-578206D3-DF84-41FA-9DB9-EE703FB1E63DQ37667327-50DFBABC-7E0A-4AE2-849A-8202A6A39EF2Q37670480-85F15E62-A047-4D0D-A71D-B908B7FC3E82Q37717019-5CE4C4C8-2ABC-4214-9BDC-ACB6DD073DF4Q38249023-FC42328A-7704-40A9-9167-074C75A436BA
P2860
Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Ischemic preconditioning poten ...... by targeting Mecp2 via miR-22
@ast
Ischemic preconditioning poten ...... by targeting Mecp2 via miR-22
@en
Ischemic preconditioning poten ...... by targeting Mecp2 via miR-22
@nl
type
label
Ischemic preconditioning poten ...... by targeting Mecp2 via miR-22
@ast
Ischemic preconditioning poten ...... by targeting Mecp2 via miR-22
@en
Ischemic preconditioning poten ...... by targeting Mecp2 via miR-22
@nl
prefLabel
Ischemic preconditioning poten ...... by targeting Mecp2 via miR-22
@ast
Ischemic preconditioning poten ...... by targeting Mecp2 via miR-22
@en
Ischemic preconditioning poten ...... by targeting Mecp2 via miR-22
@nl
P2093
P2860
P3181
P1433
P1476
Ischemic preconditioning poten ...... by targeting Mecp2 via miR-22
@en
P2093
Mashhood Wani
Muhammad Ashraf
Yuliang Feng
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0088685
P407
P577
2014-01-01T00:00:00Z